Skeletal Dysplasia Account Manager - Washington, D.C.

Drive the commercial launch of Infigratinib for achondroplasia by building and executing a Northeast territory business plan. You’ll develop partnerships with geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multidisciplinary clinic teams to meet sales goals. Use deep product and disease expertise to lead compliant, clinically relevant discussions, anticipate territory challenges using sales data, and collaborate across BridgeBio to expand advocacy and ensure “One Bridge” execution.